| Serial Number | 97694234 |
| Word Mark | REACX |
| Filing Date | Monday, November 28, 2022 |
| Status | 732 - THIRD EXTENSION - GRANTED |
| Status Date | Monday, August 25, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, January 2, 2024 |
| Goods and Services | Pharmaceutical preparations for the treatment of addiction to and abuse of alcohol, opiates, narcotics and other addictive or habit forming substances, for central nervous disorders, cancer, hematological disorders, endocrine disorders, metabolic disorders, inflammatory disorders, gastrointestinal disorders, liver disease, heart disorders, lung and bronchial disease, blood cardiovascular disease, circulatory system disease, intestinal disorders, bone disease, autoimmune disorders and disorders of the immune systems, infectious disease and enzyme deficiency disease; implantable delivery systems comprised of a subcutaneous drug delivery device sold filled with sustainable release pharmaceutical preparations used in the treatment of addiction to and abuse of alcohol, opiates, narcotics and other addictive or habit forming substances, central nervous disorders and other serious and life-threatening diseases, cancer, hematological disorders, endocrine disorders, metabolic disorders, inflammatory disorders, gastrointestinal disorders, liver disease, heart disorders, lung and bronchial disease, blood cardiovascular disease, circulatory system disease, intestinal disorders, bone disease, autoimmune disorders and disorders of the immune systems, infectious disease and enzyme deficiency disease; pharmaceuticals, namely, implantable drug delivery system comprised of a subcutaneous drug delivery device sold filled with a polymer-based subdermal matrix formulation for the sustained release of drugs in the treatment of opiate addiction; pharmaceuticals, namely, implantable drug delivery system comprised of a subcutaneous drug delivery device sold filled with a polymer-based matrix formulation for the sustained release of drugs in the treatment of central nervous system disorders and other serious and life-threatening diseases |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 1, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | NOT AVAILABLE |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 01 - Individual |
| Address | Pasadena, CA 91104 |
| Party Name | NOT AVAILABLE |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 01 - Individual |
| Address | Pasadena, CA 91104 |
| Event Date | Event Description |
| Thursday, December 1, 2022 | NEW APPLICATION ENTERED |
| Thursday, December 1, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, August 10, 2023 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Thursday, September 7, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, September 13, 2023 | NON-FINAL ACTION WRITTEN |
| Wednesday, September 13, 2023 | NON-FINAL ACTION E-MAILED |
| Wednesday, September 13, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, November 6, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, November 6, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Monday, November 6, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, November 6, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Monday, November 27, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, December 13, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, January 2, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, February 27, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, August 6, 2024 | SOU EXTENSION 1 GRANTED |
| Tuesday, August 6, 2024 | SOU EXTENSION 1 FILED |
| Tuesday, January 2, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 6, 2024 | SOU TEAS EXTENSION RECEIVED |
| Monday, February 24, 2025 | SOU EXTENSION 2 FILED |
| Monday, February 24, 2025 | SOU EXTENSION 2 GRANTED |
| Tuesday, August 6, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, February 24, 2025 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, February 25, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, August 25, 2025 | SOU TEAS EXTENSION RECEIVED |
| Monday, August 25, 2025 | SOU EXTENSION 3 FILED |
| Monday, August 25, 2025 | SOU EXTENSION 3 GRANTED |
| Tuesday, August 26, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |